REDUCED SYNTHESIS OF TISSUE PLASMINOGEN-ACTIVATOR BY VASCULAR ENDOTHELIUM DURING ACUTE MYOCARDIAL-INFARCTION

被引:3
|
作者
NORRIS, RM [1 ]
OCKELFORD, PA [1 ]
CROSS, DB [1 ]
RIVERS, JT [1 ]
SMITH, JM [1 ]
TAKAYAMA, M [1 ]
WHITE, HD [1 ]
机构
[1] AUCKLAND HOSP,DEPT HAEMATOL,AUCKLAND 3,NEW ZEALAND
来源
关键词
TISSUE PLASMINOGEN ACTIVATOR; CORONARY THROMBOSIS; VONWILLEBRAND FACTOR;
D O I
10.1111/j.1445-5994.1992.tb02122.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We measured levels of tissue plasminogen activator (t-PA) antigen in 100 patients within six hours of the onset of acute myocardial infarction, in 34 patients with chronic angina but no recent infarction, and in 36 normal subjects. We also assayed von Willebrand factor in the acute patients and in the normal subjects. Measurements were repeated in 40 acute patients at three weeks after myocardial infarction. Although resting levels of t-PA antigen were not significantly different from normal during myocardial infarction, the capacity of the vascular endothelium to release t-PA after five minutes of venous occlusion was impaired (p < 0.01). The acute phase vessel wall release of von Willebrand factor was increased during acute infarction (p < 0.01). We conclude that impairment of t-PA production is associated with acute coronary thrombosis, although it is not possible to differentiate between a causative role or a secondary response due to exhaustion of the t-PA producing mechanism.
引用
收藏
页码:261 / 264
页数:4
相关论文
共 50 条
  • [41] EFFECTIVENESS OF MULTIPLE BOLUS ADMINISTRATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    KHAN, MI
    HACKETT, DR
    ANDREOTTI, F
    DAVIES, GJ
    REGAN, T
    HAIDER, AW
    MCFADDEN, E
    HALSON, P
    MASERI, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (16): : 1051 - 1056
  • [42] BLEEDING COMPLICATIONS AFTER RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR AND CORONARY ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION
    KLINE, E
    GORMAN, L
    CIRCULATION, 1986, 74 (04) : 292 - 292
  • [43] COMPARISON OF HEPARIN AND ASPIRIN AS ADJUNCTIVE THERAPY WITH TISSUE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION - REPLY
    HSIA, J
    ROSS, AM
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17): : 1218 - 1218
  • [44] ON THE PREDICTIVE VALUE OF PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE PLASMINOGEN-ACTIVATOR ASSAYS IN SURVIVORS OF MYOCARDIAL-INFARCTION - A PROSPECTIVE-STUDY
    NILSSON, TK
    JANSSON, JH
    JOHNSON, O
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 575 - 575
  • [45] DOES STREPTOKINASE BUT NOT TISSUE-TYPE PLASMINOGEN-ACTIVATOR ATTENUATE PLATELET-AGGREGATION DURING ACUTE MYOCARDIAL-INFARCTION
    KARLBERG, KE
    HAGERMAN, I
    CHEN, JH
    BERGSTROM, K
    SYLVEN, C
    CIRCULATION, 1992, 86 (04) : 715 - 715
  • [46] MONITORING OF FIBRIN GENERATION DURING THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    RAPOLD, HJ
    KUEMMERLI, H
    WEISS, M
    BAUR, H
    HAEBERLI, A
    CIRCULATION, 1989, 79 (05) : 980 - 989
  • [47] ENHANCED PATENCY WITH EARLY INFUSION OF DOUBLE-CHAIN TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    KALBFLEISCH, J
    KURNIK, PB
    DEWOOD, M
    CLINICAL RESEARCH, 1989, 37 (02): : A269 - A269
  • [48] CIRCADIAN FLUCTUATIONS OF PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE PLASMINOGEN-ACTIVATOR LEVELS IN PLASMA OF PATIENTS WITH UNSTABLE CORONARY-ARTERY DISEASE AND ACUTE MYOCARDIAL-INFARCTION
    HUBER, K
    ROSC, D
    RESCH, I
    SCHUSTER, E
    GLOGAR, DH
    KAINDL, F
    BINDER, BR
    THROMBOSIS AND HAEMOSTASIS, 1988, 60 (03) : 372 - 376
  • [49] RECOMBINANT DOUBLE CHAIN TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION - AN INTRAVENOUS DOSE RANGING STUDY
    TURI, ZG
    CLINICAL RESEARCH, 1987, 35 (03): : A576 - A576
  • [50] RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION - ROLE OF THE CRITICAL CARE NURSE
    KLINE, EM
    HEART & LUNG, 1987, 16 (06): : 779 - 786